Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,579Revenue $M274Net Margin (%)30.5Z-Score26.2
Enterprise Value $M1,428EPS $1.6Operating Margin %47.7F-Score7
P/E(ttm))16.6Cash Flow Per Share $0.4Pre-tax Margin (%)48.2Higher ROA y-yY
Price/Book4.710-y EBITDA Growth Rate %0Quick Ratio6.0Cash flow > EarningsN
Price/Sales5.15-y EBITDA Growth Rate %55.3Current Ratio7.1Lower Leverage y-yY
Price/Cash Flow14.2y-y EBITDA Growth Rate %966ROA % (ttm)33.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)38.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M35.8ROI % (ttm)8.9Gross Margin Increase y-yY

Gurus Latest Trades with LCI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
LCIJoel Greenblatt 2014-09-30 Add0.12%$34.05 - $51.19
$ 44.1511%Add 749.49%303,345
LCIJoel Greenblatt 2014-06-30 Buy 0.02%$29.62 - $49.76
$ 44.1513%New holding, 35709 sh.35,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LCI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LCI Joel Greenblatt 2014-09-30303,3450.850.14+749.49%
Premium Most recent portfolio changes are included for Premium Members only!

LCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEDROSIAN ARTHUR PCEO 2014-12-15Sell5,000$43.810.78view
FARBER DAVID10% Owner 2014-12-15Sell5,000$43.810.78view
Maher James M.Director 2014-12-10Buy250$42.962.77view
GALVAN MARTIN PVP of Finance & CFO 2014-12-10Buy1,000$42.44.13view
Sabo ErnestVP, Regulatory and CCO 2014-12-08Sell6,000$48.03-8.08view
Maher James M.Director 2014-12-02Buy500$46.53-5.11view
FARBER DAVID10% Owner 2014-11-26Sell7,500$50-11.7view
Sabo ErnestVP, Regulatory and CCO 2014-11-26Sell3,000$50.04-11.77view
Maher James M.Director 2014-11-21Buy500$45.08-2.06view
FARBER DAVID10% Owner 2014-11-17Sell5,000$47.7-7.44view

Press Releases about LCI :

    Quarterly/Annual Reports about LCI:

    News about LCI:

    Articles On GuruFocus.com
    comment on LCI Nov 19 2012 
    comment on LCI Nov 13 2012 
    comment on LCI Jan 26 2012 
    comment on LCI Jan 26 2012 
    comment on LCI Jan 23 2012 
    comment on LCI Jan 23 2012 
    Lannett Company Inc Reports Operating Results (10-Q) Nov 12 2010 
    Lannett Company Inc Reports Operating Results (10-K) Sep 24 2010 
    View on LCI May 17 2010 
    Lannett Company Inc Reports Operating Results (10-Q) May 13 2010 

    More From Other Websites
    Lannett Receives FDA Approval for Dorzolamide HCL with Timolol Dec 18 2014
    Stocks Off Lows In Afternoon: AutoZone Hits New High Dec 09 2014
    Cempra (CEMP) in Focus: Stock Rises 11.4% in Session Dec 09 2014
    Tetraphase Pharmaceuticals (TTPH) Jumps: Stock Up 8.8% Dec 09 2014
    LANNETT CO INC Files SEC form 8-K, Other Events Dec 08 2014
    LANNETT CO INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Dec 05 2014
    Lannett Names Michael Bogda as President Dec 05 2014
    Ryanair Holdings (RYAAY) Jumps: Stock Adds 7.2% in Session Dec 05 2014
    Lannett to Present at the Oppenheimer 25th Annual Healthcare Conference on December 10 Dec 02 2014
    Otonomy (OTIC) Jumps: Stock Adds 5.7% in Session Dec 02 2014
    Insider Trading Alert - OLBK, CSC And LCI Traded By Insiders Nov 25 2014
    Why Lannett (LCI) Could Be a Potential Winner Nov 25 2014
    LANNETT CO INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 20 2014
    Insider Trading Alert - BEAV, LCI And OC Traded By Insiders Nov 20 2014
    CytRx Falls on Partial Study Hold on Oncology Candidate Nov 19 2014
    Lannett Announces Retirement of Executive Officer Nov 17 2014
    Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded Nov 14 2014
    LANNETT CO INC Financials Nov 14 2014
    Flamel Technologies (FLML) in Focus: Stock Rises 11% Nov 14 2014
    Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher Nov 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial